Primmune Therapeutics News and Activities

Acquisition, funding and merger involving Primmune Therapeutics.

• Primmune Therapeutics has just announced a $23 Million fundraising (posted on February 12 2026).

View the org chart displaying its 10 main executives

Most searched biographies at Primmune Therapeutics

• Charles Mcdermott, President, Chief Executive Officer and Director
• Tom Heyman, Director
• Debora Dumont, Director

Popular executive movements at Primmune Therapeutics

• Andrew Sharabi has joined the company as Chief Medical Officer  (posted on February 12 2026).
• Chris Krueger has joined the company as Executive Chairman of the Board  (posted on February 12 2026).

Create your alert
to follow the executive moves at Primmune Therapeutics.

Primmune Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Primmune Therapeutics

• Primmune Therapeutics Appoints Chief Medical Officer and Executive Board Chair; Establishes Melanoma Clinical Study Advisory Board - Primmune

Social media about Primmune Therapeutics

• Primmune Therapeutics on Wikipedia, Google News & Yahoo Finance
• Primmune Therapeutics on LinkedIn, X (Twitter) & YouTube